January « 2016 « Science and Enterprise

Students Design Pad to Collect Urinary Infection Samples

By Alan, on January 14th, 2016%

UCap microfiber pad (Hebrew University of Jerusalem)

14 January 2016. A team at Hebrew University in Jerusalem designed a microfiber pad to improve collection of urine samples from people with urinary tract infections. Graduate students from a number of disciplines developed the pad under in the Israeli university’s Biodesign medical innovation program.

Infections . . . → Read More: Students Design Pad to Collect Urinary Infection Samples

Yahoo Releases User Interaction Data for Machine Learning

By Alan, on January 14th, 2016%

(Suresh Subbaiah, Wikimedia Commons)

14 January 2016. The online company Yahoo is releasing an extensive data set of individual user interactions with some of its popular services to the academic community as raw material for studies of machine learning. The de-identified data sets will be part of Yahoo’s Webscope reference library offered to . . . → Read More: Yahoo Releases User Interaction Data for Machine Learning

Boehringer, Arena to Discover Neurological Drugs

By Alan, on January 13th, 2016%

(Arthur Toga, UCLA/NIH.gov)

13 January 2016. Pharmaceutical companies Boehringer Ingelheim and Arena Pharmaceuticals Inc. are collaborating on discovery of new therapies for schizophrenia and other neurological disorders. The partnership could bring Arena, in San Diego, as much as $262 million.

Arena Pharmaceuticals is a biopharmaceutical company developing therapies for disorders related to G . . . → Read More: Boehringer, Arena to Discover Neurological Drugs

Smart Pills Detect, Measure Gases in Gut

By Alan, on January 13th, 2016%

Gas-sensing intestinal capsule (RMIT University)

13 January 2016. A team at RMIT University in Australia developed a device, swallowed like a pill, that measures gas concentrations in the intestine and sends its data to an outside receiver. Proof-of-concept results from tests with pigs appear in the January 2016 issue of the journal Gastroenterology.

. . . → Read More: Smart Pills Detect, Measure Gases in Gut

Gates Funding RNA Treatment for HIV Infection

By Alan, on January 12th, 2016%

RNA molecule illustration (Nicolle Rager Fuller, National Science Foundation)

12 January 2016. The Bill and Melinda Gates Foundation is backing a biotechnology company’s early development of antibodies to treat human immunodeficiency virus or HIV based on RNA, nucleic acids expressed by a person’s genetic code. The foundation is supporting the work of Moderna . . . → Read More: Gates Funding RNA Treatment for HIV Infection

Zika Virus Genome Sequenced

By Alan, on January 12th, 2016%

(CDC.gov)

12 January 2016. A team from Institut Pasteur in French Guiana sequenced the complete genome of the Zika virus, a mosquito-borne pathogen causing disease outbreaks in tropical regions, including the Americas. Findings from the analysis appeared last week in the journal The Lancet.

The Zika virus causes fever, with rash, joint pain, . . . → Read More: Zika Virus Genome Sequenced

Trials Show Safety, Benefit of Stem Cells to Treat ALS

By Alan, on January 11th, 2016%

(AllanAjifo, Wikimedia Commons)

11 January 2016. Two clinical trials testing stem cells to treat amyotrophic lateral sclerosis, or ALS, found the treatments are safe for patients, and can slow progression of the disease. Results of the trials testing the stem cell product known as NurOwn made by BrainStorm Cell Therapeutics in Petach Tikvah, . . . → Read More: Trials Show Safety, Benefit of Stem Cells to Treat ALS

Juno Acquires Biotech, Licenses Cell Sequencing Tech

By Alan, on January 11th, 2016%

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

11 January 2016. Juno Therapeutics is gaining single-cell sequencing technology for cancer immunotherapies through the buy-out of biotechnology company AbVitro Inc., and licensing part of that technology to pharmaceutical company Celgene Corp. The AbVitro acquisition is valued . . . → Read More: Juno Acquires Biotech, Licenses Cell Sequencing Tech

Grünenthal Group to Commercialize Duchenne Therapy

By Alan, on January 8th, 2016%

Cross-section of muscle tissue from a person with Duchenne muscular dystrophy shows extensive replacement of dark colored muscle fiber with light-colored adipose or fat cells. (Centers for Disease Control and Prevention)

8 January 2015. Grünenthal Group, a German pharmaceutical company, is licensing a treatment candidate for Duchenne muscular dystrophy developed by Akashi Therapeutics, . . . → Read More: Grünenthal Group to Commercialize Duchenne Therapy

Biotechs to Develop Antibody Therapies, Explore Merger

By Alan, on January 8th, 2016%

Downtown Vancouver (Magnus Larsson, Flickr)

8 January 2016. Two biotechnology companies in Vancouver agreed to collaborate on developing antibody treatments for cancer, with an option to merge their enterprises later on. The deal calls for Zymeworks Inc. to make an undisclosed equity investment in Kairos Therapeutics Inc. Zymeworks is also receiving $US 61.5 . . . → Read More: Biotechs to Develop Antibody Therapies, Explore Merger

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise